Has Brittney Owen received payments from drug or device companies?

Yes. Drug and device makers reported $2,014 in general payments to Brittney Owen across 118 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brittney Owen did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brittney Owen come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brittney Owen

Family · Crown Point, INNPI 1184092579

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 28.9% of the total. Reporting peaked in 2021 at $1,269 and has fallen 98.4% since, to $20 in 2025.

$2,014in general payments, 2019–2025

Across 118 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$582
AstraZeneca$163
Astellas Pharma US Inc$146
Takeda Pharmaceuticals U.S.A., Inc.$114
Otsuka America Pharmaceutical, Inc.$102
Antares Pharma, Inc.$97
plus $809 from 25 others

What the payments were for

Food & beverage$2,014100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	33	$582
AstraZeneca	11	$163
Astellas Pharma US Inc	8	$146
Takeda Pharmaceuticals U.S.A., Inc.	7	$114
Otsuka America Pharmaceutical, Inc.	5	$102
Antares Pharma, Inc.	7	$97
Lilly USA, LLC	4	$76
Esperion Therapeutics, Inc.	4	$73
Boehringer Ingelheim	4	$69
Amgen	3	$51
Clarus Therapeutics Inc.	3	$44
Itamar Medical Inc	1	$44
Alkermes, Inc.	2	$43
Novo Nordisk	2	$36
Sanofi-aventis U.S. LLC	2	$35
Corium, LLC	2	$33
Amarin Pharma, Inc.	2	$31
Pfizer	2	$31
Merck	2	$30
Ironwood Pharmaceuticals, Inc	2	$28
Biohaven Pharmaceutical Holding Company Ltd.	1	$22
Orexo US, Inc.	1	$20
Genentech USA, Inc.	2	$20
Sunovion Pharmaceuticals Inc.	1	$19
Insulet Corporation	1	$18
Lundbeck LLC	1	$17
Collegium Pharmaceutical, Inc.	1	$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$16
Indivior Inc.	1	$13
Avion Pharmaceuticals	1	$13
GSK	1	$12

How this compares

$2,014 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Phenobarbital	13	$36

Paid to pharmacies, not to this prescriber.

Other family in Crown Point

Tina SizemoreIndianapolis$888K
Kathalene Keller RineyEvansville$383K
Robin AndersonPortage$333K
Marla MosesIndianapolis$142K
Justin BrownFort Wayne$142K
Lacey MatheisEvansville$139K
Myra SikwataHobart$131K
Elizabeth JohnsonEvansville$108K
Beverly MaugerFt Wayne$94K
Nancy ArndtPortage$91K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →